Articles tagged with Stem Cell Differentiation
Scientists have developed a new method to create self-renewing stem cells specific to the human foregut, opening up possibilities for regenerative therapies. The breakthrough technique allows for the growth of pure liver or pancreatic cells in sufficient quantities for clinical use, overcoming current limitations.
Researchers have discovered that non-adherent bone marrow stem cells can differentiate into neuronal-like cells in vitro and in vivo. These findings suggest that non-adherent BMSCs could be used as seed cells to treat nervous system diseases.
A Penn study found that lamin-A, a protective protein in the nucleus, plays a key role in regulating stem cell differentiation and tissue stiffness. The research revealed a correlation between lamin-A levels and elasticity in various tissues.
Researchers developed a protocol for isolating and expanding large numbers of multipotent fetal dermal cells (MFDCs) that display several advantages over adult dermal cells, including greater cellular yield after isolation and the retention of differentiation potential. The MFDCs were proven safe and efficacious in treating pediatric b...
Researchers at the University of Pittsburgh School of Medicine have successfully regenerated a mouse heart using human heart precursor cells, paving the way for potential transplantation and drug testing models. The breakthrough could lead to personalized organ replacement and improved treatment options for heart disease patients.
HSCI researchers mapped nearly all cytosine-guanine pairs in human DNA and found that only a small fraction are dynamic, playing a key role in regulating gene expression. The study improves current approaches to mapping epigenetic marks and sheds light on how genes are controlled in different cell types.
A new study by UCSF researchers has identified a key protein called BMI1 that plays a vital role in ensuring normal tissue development. The findings suggest that manipulating BMI1 could be a strategy for creating cell-based treatments to replace damaged tissues and potentially slow tumor growth.
Researchers at the Salk Institute have developed a more versatile method for creating induced pluripotent stem cells (iPSCs), which can be tailored to individual patients. By adjusting the balance of genes required for differentiation, scientists can create iPSCs with greater flexibility and potential for clinical application.
Researchers in Granada have successfully generated bone tissue from umbilical cord stem cells using a novel biomaterial. The breakthrough could lead to the development of new treatments for bone and cartilage lesions, as well as the regeneration of bones in patients with osseous system pathologies.
Scientists engineer stem cells using gelatin-based microparticles to deliver growth factors, providing localized control of cell differentiation. This technique reduces the need for growth factor, a crucial cost consideration for manufacturing stem cells.
A novel approach to create human red blood cells and platelets in vitro has been identified by researchers at Boston University School of Medicine. This finding could potentially reduce the need for blood donations, speed up research on therapies to treat diseases such as sickle cell disease.
Researchers developed a new laboratory method to detect and measure the mechanics of single-molecule interactions, revealing a well-defined 'quantum of force' required to activate cell adhesion. The findings have broad applications for research into stem cells, cancer, infectious disease, and immunology.
A collaborative study reveals how modifications in key epigenetic markers influence human embryonic stem cells as they differentiate into specialized cells. The findings provide insights into processes during early human development and tissue formation.
A study found that growth differentiation factor 11 (GDF11) declines with age and can reverse signs of cardiac aging in old mice. The discovery sheds light on the underlying causes of age-related heart failure, offering a potential treatment strategy.
Researchers found that amniotic fluid stem cells can communicate with mature heart cells through channels in the membrane, forming functional gap junction connections. However, these cells do not differentiate into cardiac tissue under these conditions.
A UCSB researcher has identified a protein molecule that helps maintain adult stem cells in fruit flies, revealing insights into regenerative medicine. The study found that this protein, castor, plays a critical role in specifying brain cell types during embryonic development and maintaining follicle stem cells throughout life.
A team of researchers has discovered multipotent stem cells in deer antlers, which can differentiate into multiple cell types and have the potential to treat various injuries in veterinary medicine. The study highlights a novel source of stem cells for use in regenerative therapies.
VeriStem Technologies has developed an antibody that selectively targets and kills undifferentiated stem cells, reducing the risk of tumour formation. The company's Cellradication technology has the potential to revolutionize stem cell therapies and bring significant improvements to the healthcare industry.
Researchers from University of Copenhagen identify Fbxl10 as crucial for embryonic stem cell differentiation and suggest it as a potential target for cancer therapy. The protein recruits Polycomb complexes to silence genes, maintaining cellular identity.
Researchers at Monash University successfully derived and purified lens epithelium, paving the way for testing new drugs on human tissue. The breakthrough could lead to cures for congenital sight impairment caused by lens damage, particularly in developing countries.
Researchers developed an efficient method to induce human induced pluripotent stem (iPS) cells into intermediate mesoderm, the precursor of kidney cells. The protocol achieved a high success rate of 90% or more and successfully generated renal tubule structures.
Researchers at BUSM demonstrate that tissues derived from patient-specific induced pluripotent stem (iPS) cells are not rejected when transplanted back into genetically identical recipients. The study finds that differentiated iPS cells can mature into various cell types, including neuronal, hepatocyte, and endothelial cells, without i...
Scientists have successfully reprogrammed one type of neuron into another within the brain, challenging the long-held notion that neurons are immutable. This breakthrough has significant implications for treating neurodegenerative diseases such as ALS.
Scientists have made significant progress towards developing a potential stem cell therapy for diabetes. The study found that human embryonic stem cells (hESCs) can differentiate into endocrine cells that are remarkably similar to primary human counterparts. However, hESC-derived endocrine cells produced in vitro lack key features and ...
A team of scientists has made a groundbreaking discovery about the role of brassinosteroid hormone in plant organ development, shedding light on how plants form their organs and boundaries. The research found that activation of the brassinosteroid pathway represses genes responsible for organ boundary formation, leading to fused organs.
Scientists at Stanford Medicine have found a way to let the body direct differentiation of transplanted stem cells without forced manipulation. This breakthrough could speed FDA approval and enable new therapies using pluripotent stem cells.
A NIST team developed a model to predict cell behavior and change, using a data-driven landscape approach. The method provides reliable numbers for the complex evolution of cell populations, crucial for biomanufacturing and stem cell therapies.
A team of scientists has discovered a critical protein, Utf1, that balances activation and deactivation of genes for cell differentiation. This finding sheds light on the complex process of embryonic stem cell self-renewal and differentiation.
Researchers have developed a new technique to study how myeloids become white blood cells, providing new insights into the molecular mechanisms at work during this process. This approach offers potential improvements in treating myeloid diseases like leukemia by identifying key regulatory pathways and developing therapeutic strategies.
A recent study has revealed the existence of a rare sub-group of activated immune cells that act as bodyguards to protect stem cells from premature differentiation. These macrophage cells secrete prostaglandins, which delay differentiation and preserve the youthful state of the stem cells.
A research team at New York University has determined how cells that cause inflammatory ailments differentiate from stem cells. The study found hundreds of new genes involved in the function and development of these cells, which can be used to design new therapies for diseases such as Crohn's disease, multiple sclerosis, and arthritis.
A team of Japanese researchers found that using specific transcription factors and Sendai virus vectors can facilitate the differentiation of mouse pancreatic stem cells (mPSCs) into insulin-producing cells. The combination of Pdx-1, NeuroD, and MafA transcription factors showed the greatest impact on this process.
Researchers have successfully imaged cells growing on spherical surfaces using a novel class of substrates. This technique has potential applications in cancer detection and treatment, as well as stem cell differentiation and tissue engineering.
Researchers have identified melanoma stem cells marked by the enzyme ALDH, which exhibit high tumorigenicity and resistance to chemotherapy. Targeting these cells with a new therapy could boost the effectiveness of existing drugs.
Researchers at Michigan Medicine have discovered the crucial role of Mof in preserving stem cells' ability to become any type of cell. By regulating DNA access, Mof enables stem cells to maintain their 'stem-ness' and differentiate into specialized cells.
Researchers have identified a biochemical marker, SSEA4, that can be used to identify and purify human pancreatic stem cells. These stem cells can differentiate into insulin-producing cells when grown in culture with high glucose levels, potentially offering a new approach for treating type 1 diabetes.
A new Weizmann Institute-led study identifies a potential molecular mechanism behind the link between cancer and faulty stem cell differentiation. The researchers discovered that the tagging of DNA pieces with ubiquitin is crucial for proper stem cell differentiation, and disruptions in this process can lead to cancer.
Researchers at Hebrew University of Jerusalem identified mechanisms allowing embryonic stem cells to become any cell type by examining epigenetic pathways and chromatin structure. This discovery could lead to the creation of cells in labs for treating Alzheimer's, Parkinson's, and other degenerative diseases.
Scientists have identified proteins as the key to maintaining self-renewal in human epidermal progenitor cells and stem cells. The discovery highlights the importance of exosomes in regulating transcription factors, enabling cells to produce new skin cells throughout life.
A novel gene variant associated with reduced cholesterol levels has been identified in human populations. Additionally, a new approach for treating Parkinson's disease using embryonic stem cell therapy is proposed. Furthermore, research suggests that brain indoleamine 2,3-dioxygenase 1 (IDO1) plays a crucial role in the concurrence of ...
Researchers have developed a technique to reprogram adult cells from patients with limb-girdle muscular dystrophy into stem cells, which can then be genetically modified and transplanted into mice. The study shows promise for treating this rare form of muscular dystrophy.
Researchers at the Salk Institute found that embryonic stem cells enter a unique, privileged state during early embryo development where specific genes are activated, allowing them to differentiate into any cell type. This discovery may provide insight into how to improve the clinical value of ES cells for therapy.
A Stanford researcher discovered that certain human embryonic stem cells produce molecules that benefit themselves and nearby cells during stress, exhibiting 'altruistic' behavior. This unique trait is linked to an increase in p53 protein fluctuations, enabling some stem cells to maintain their stemness and secrete antioxidant glutathi...
A study by UT Southwestern Medical Center researchers has identified a protein receptor on cancer cells that induces differentiation, helping blood cancer cells grow. The receptor, called LILRB2, maintains stem cell readiness by inhibiting differentiation and preserving self-renewal.
The Maryland Stem Cell Research Fund has awarded grants to 29 Johns Hopkins researchers working on stem cell metabolism, disease modeling, and therapy development. New therapies aim to replace damaged cells in patients with conditions like schizophrenia and Rett syndrome.
Scientists at Johns Hopkins Medicine have discovered a protein that regulates brain development by blocking Notch proteins. The discovery, published in Developmental Cell, sheds light on developmental disorders and conditions involving new neuron generation.
Embryonic stem cells that lack DNA compaction are unable to fully differentiate into specific cell types. Chromatin compaction is required for proper embryonic stem cell differentiation to occur, and its absence impairs the suppression of pluripotency genes and leads to impaired differentiation.
Researchers at UCLA identified new genetic components controlling neural stem cell adhesion and proliferation, crucial for normal nervous system development. The study's findings could lead to a better understanding of birth defects and disorders like autism, as well as the formation of brain tumors.
Researchers suggest that stem cells have intrinsic capacities for self-maintenance and evasion of differentiation. By analyzing current properties and characteristics of stem cells, the 'by default' hypothesis proposes that stem cells exist due to factors that repress cellular signals for specialization.
Researchers have developed a unique suspension technique for growing stem cells, eliminating the need for surface growth and increasing efficiency. This breakthrough has the potential to make cost-effective large-scale stem cell manufacturing possible, which could lead to new treatments for heart disease.
Researchers found that insulin and nutritional factors help maintain the 'stemness' of blood stem cells in fruit flies. The study's implications include a potential connection between metabolic disruptions and chronic inflammation in humans.
Scientists at Northwestern University developed a powerful analytical method called nanocombinatorics to rapidly identify the chemical and physical structures that cue stem cells to become osteocytes. The researchers successfully directed stem cell differentiation without additional chemical cues, demonstrating better control than curr...
Researchers from the University of Victoria have developed a new 3D stem cell culture method, enabling scientists to study cell behavior in conditions similar to those in the body. This breakthrough has significant implications for regenerative medicine and other fields.
Researchers at UGA created the first blueprint of how stem cells respond to external signaling molecules. The finding reconciles years of conflicting results and enables precise control over stem cell differentiation into specific cell types.
Researchers identified PDGF-B signaling in trophoblasts as a vital component of the placental niche, supporting blood stem cell generation and expansion without promoting differentiation. This discovery provides new insights into regulating EPO expression and governing the fates of blood stem cells during development.
Scientists at Whitehead Institute have made a breakthrough in understanding planarian stem cells, discovering genes that regulate two main functions: differentiation and renewal. The study, published in Cell Stem Cell, provides insights into the molecular mechanisms underlying regenerative medicine.
Researchers discovered that high levels of Amd1, an enzyme in the polyamine synthesis pathway, are essential for maintaining embryonic stem cells' (ESCs) self-renewal ability. The study also found that manipulating polyamine levels could help direct ESC differentiation into clinically useful cell types.
Researchers have successfully differentiated human dental pulp stem cells into liver cells using hydrogen sulphide, producing high numbers of pure cells. This breakthrough offers promising results for future liver-cell therapy and transplantation without the risk of teratomas or cancers.
Research reveals LSD1's key function in silencing embryonic stem cell genes during differentiation, allowing cells to adopt new operating systems. The findings hold broader implications for understanding defective operating systems in diseases like cancer.
Researchers in Canada have developed a technique to produce large quantities of endoderm cells from human pluripotent stem cells, overcoming a key hurdle in regenerative medicine. The method allows for significant increases in effective cell production, enabling the potential for regenerative treatments for diabetes and liver disease.